Medicus Pharma Ltd.
Stock exchange listing-rule deficiency notice (8-K Item 3.01)
The company reported in a Form 8-K (Item 3.01) filed on 27 May 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.
More details →Stock exchange listing-rule deficiency notice (8-K Item 3.01)
The company reported in a Form 8-K (Item 3.01) filed on 24 Apr 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.
More details →Medicus Pharma Ltd. — Overview & Financial Snapshot
Medicus Pharma Ltd. (NasdaqCM: MDCX) is a Healthcare company, ranked #6,730 of 6,774 companies globally and #3,960 of 4,000 in United States on PositoAI, with a Positivity Score of -99,421. Its market capitalisation is ₹35.47 Cr ($3.76M), P/E ratio is -0.0 and P/B ratio is -2.13. It currently has 2 active red flags (PosiRed) and no yellow flags (PosiYellow) on record.
For financial statements, ratio trends and score history, Go Deep →